(:GRNA)

Jul 24, 2023 09:49 am ET
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc. (“Parent”), pursuant to which Merger Sub...
Jul 20, 2023 08:06 am ET
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc...
Jun 23, 2023 12:14 pm ET
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA
NEW YORK, June 23, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jun 16, 2023 10:29 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, TESS, FRG, GRNA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Focus Financial Partners Inc. (NASDAQ:...
Jun 15, 2023 10:00 am ET
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GreenLight Biosciences Holdings and Encourages Long-Term GRNA / ENVI Shareholders to Contact the Firm
PHILADELPHIA, June 15, 2023 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating GreenLight Biosciences Holdings (NASDAQ: GRNA) ("GreenLight") on behalf of the company's long-term shareholders.
Jun 11, 2023 09:59 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRNA, CIR, REUN
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: GreenLight Biosciences Holdings, PBC...
Jun 07, 2023 04:54 pm ET
ALERT: The M&A Class Action Firm Continues Investigating the Merger – VKIN, GRNA, FRG, AAIC
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Jun 06, 2023 09:38 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FRG, HMPT, GRNA
NEW YORK     , June 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jun 05, 2023 01:12 pm ET
GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight Biosciences
NEW YORK, June 5, 2023 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:
Jun 03, 2023 08:17 pm ET
Lifshitz Law PLLC Announces Investigations of GRNA, AAIC, EMBK, and REUN
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of GRNA to a group of buyers led by Fall Line Capital, LLC for $0.30...
Jun 01, 2023 05:54 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMBK, AAIC, GRNA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Embark Technology, Inc. (NASDAQ:...
May 31, 2023 09:42 pm ET
GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of GreenLight Biosciences Holdings, PBC (NasdaqGM: GRNA) to a consortium led by Fall Line Capital, LLC. Under the terms of the proposed transaction, shareholders of GreenLight will receive $0.30 in cash for each share of GreenLight that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
May 31, 2023 04:51 pm ET
ALERT: The M&A Class Action Firm Continues Investigating the Merger – FRG, GRNA, EMBK, AAIC
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
May 30, 2023 10:05 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRNA, AAIC, CWBR, EMBK
NEW YORK, May 30, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
May 30, 2023 10:45 am ET
Shareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall Line
MILWAUKEE, May 30, 2023 /PRNewswire/ -- Ademi LLP is investigating GreenLight (NASDAQ: GRNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Fall Line. 
May 30, 2023 08:29 am ET
GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) to a group of buyers led by Fall Line Capital, LLC for $0.30 per share is fair to GreenLight shareholders.
May 30, 2023 07:01 am ET
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive agreement (the “Merger Agreement”) to be acquired by a group of buyers led by Fall Line Capital, LLC...
May 11, 2023 07:00 am ET
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences, PBC (Nasdaq: GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, today reported operational highlights and financial results for the first quarter ended...
Apr 12, 2023 06:59 am ET
GreenLight Biosciences Releases Inaugural Sustainability Report
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability...
Mar 30, 2023 04:05 pm ET
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today, confirmed...
Mar 28, 2023 05:05 pm ET
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today reported operational highlights and...
Mar 09, 2023 06:59 am ET
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, will today outline its pipeline strategy and R&D...
Mar 07, 2023 06:59 am ET
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, will today outline its pipeline strategy and R&D...
Mar 01, 2023 06:24 am ET
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today announced it will host a two-part R&D Day...
Feb 01, 2023 07:20 am ET
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today announced that it has received regulatory...
Jan 09, 2023 07:20 am ET
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
GreenLight Biosciences Holdings, PBC (Nasdaq:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers....
Nov 09, 2022 05:07 pm ET
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences Holdings, PBC (Nasdaq:GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person on our...
Nov 07, 2022 11:25 am ET
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the potential of RNA to address some of the world’s toughest problems in human health and agriculture, today announced that Dr. Andrey Zarur, CEO, and Susan...
Oct 12, 2022 06:54 am ET
GreenLight Biosciences announces realignment to focus on near-term value drivers
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person on our planet, today...
Oct 05, 2022 09:35 am ET
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
Researchers from Boston’s GreenLight Biosciences and the Queensland University of Technology (QUT) in Brisbane, Australia, have announced an agreement to develop a solution to fall armyworm, which causes more than US$2 billion in annual global crop...
Aug 15, 2022 07:30 am ET
GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person in our planet, today...
Aug 12, 2022 07:21 am ET
GreenLight Biosciences announces $109 million financing
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person on our planet, today...
Aug 04, 2022 09:39 am ET
Thinking about buying stock in ChemoCentryx, Invivo Therapeutics, Greenlight Biosciences, Missfresh, or NanoViricides?
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CCXI, NVIV, GRNA, MF, and NNVC.
Aug 01, 2022 09:00 am ET
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
GreenLight Biosciences (Nasdaq: GRNA), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing...
Jul 29, 2022 04:40 pm ET
NIH, GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants
GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and with longer-lasting effects. “This is a tremendous...
May 10, 2022 01:04 pm ET
GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award
An RNA-based solution by GreenLight Biosciences designed to protect honeybees from the Varroa destructor mite was named a finalist by Fast Company for its 2022 World Changing Ideas Awards. This is the first RNA-based solution that directly targets...
Mar 29, 2022 01:04 pm ET
Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board
GreenLight Biosciences, PBC, a biotechnology company focused on RNA research, product design, development, and manufacturing for human, animal, and plant health, is proud to welcome Barney Graham, MD, PhD., to its Human Health Scientific Advisory...
Mar 14, 2022 08:55 am ET
GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally
GreenLight Biosciences Holdings PBC today announced a licensing agreement with Serum Institute of India, Pvt, Ltd., aimed at accelerating accessibility to messenger RNA products in emerging markets globally. Serum Institute of India (SII) is the...
Feb 07, 2022 01:27 pm ET
GreenLight agrees to field station in Spain to boost research and development for key plant health projects
GreenLight Biosciences, a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced its agreement to operate a field research station in Spain. Located south of Seville, a key...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.